Successful long-term treatment of refractory Adamantiades-Behçet's disease (ABD) with infliximab: report of two patients

Adv Exp Med Biol. 2003:528:551-5. doi: 10.1007/0-306-48382-3_111.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use
  • Behcet Syndrome / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Male
  • Panuveitis / drug therapy
  • Panuveitis / etiology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab